Myelodysplastic Syndromes Concept

Vocabulary Service

MeSH

Overview

subject area of

RUNX1 mutation in a patient with myelodysplastic syndrome and decreased erythrocyte expression of blood group A antigen Journal Articles
A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186 Journal Articles
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry Journal Articles
A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies Journal Articles
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study Journal Articles
Acute leukemia in Down's syndrome. Journal Articles
An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring Journal Articles
Anabolic steroids in myelodysplastic syndromes: A systematic review Journal Articles
Azacitidine Monotherapy in Patients With Treatment-Naïve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis Journal Articles
Cellular and molecular architecture of hematopoietic stem cells and progenitors in genetic models of bone marrow failure Journal Articles
Chromosome investigations & clinical outcome in patients with myelodysplastic syndromes. Journal Articles
Clinical and biological implications of driver mutations in myelodysplastic syndromes Journal Articles
HLA-DRnegative, CD34negative Hypergranular Acute Myeloid Leukemia With Trisomy 6 and del(5)(q22q33) Journal Articles
Hepatitis-associated Aplastic Anemia Presenting as a Familial Bone Marrow Failure Syndrome Journal Articles
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes Journal Articles
High‐dose cytosine arabinoside in the treatment of preleukemic disorders: A leukemia intergroup study Journal Articles
ITACA: A new validated international erythropoietic stimulating agent‐response score that further refines the predictive power of previous scoring systems Journal Articles
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes Journal Articles
Impact of intensity of conditioning therapy in patients aged 40–60 years with AML/myelodysplastic syndrome undergoing allogeneic transplantation Journal Articles
Iron chelation therapy in patients with low‐ to intermediate‐risk myelodysplastic syndrome: A systematic review and meta‐analysis Journal Articles
Iron overload in myelodysplastic syndromes: A Canadian consensus guideline Journal Articles
Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS Journal Articles
Leukemia after Chemotherapy for Cancer Journal Articles
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia Journal Articles
MDS with del(5q) and associated cKIT D816V positive mastocytosis Journal Articles
Myelodysplastic syndrome with prolonged reticulocyte survival mimicking hemolytic disease Journal Articles
Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study Journal Articles
Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation Journal Articles
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an MDS‐CAN analysis Journal Articles
Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study Journal Articles
Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study Journal Articles
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease Journal Articles
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high‐risk myelodysplastic syndrome patients pre‐screened for low O⁶‐methylguanine DNA methyltransferase expression Journal Articles
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) Journal Articles
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms Journal Articles
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies Journal Articles
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE Journal Articles
Reduction of blood group A antigen on erythrocytes in a patient with myelodysplastic syndrome harboring somatic mutations in RUNX1 and GATA2 Journal Articles
Revised 15-item MDS-specific frailty scale maintains prognostic potential Journal Articles
Shwachman–Diamond syndrome: an inherited model of aplastic anaemia with accelerated angiogenesis Journal Articles
SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts Journal Articles
Telomerase activity in normal leukocytes and in hematologic malignancies Journal Articles
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry Journal Articles
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes Journal Articles
Therapy-Related Leukemia and Myelodysplasia in Small-cell Lung Cancer Journal Articles
Transfusion thresholds in myelodysplastic syndrome—Helping patients live better Journal Articles
Transfusion-related Iron Overload in Children With Leukemia Conferences
XXIII International Association for Comparative Research on Leukemia and Related Diseases Symposium: from Molecular Pathogenesis to Targeted Therapy in Leukemia and Solid Tumors Conferences